Diabetes Care, Vol 19, Issue 1 43-47, Copyright © 1996 by American Diabetes Association

ARTICLES

Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects

G Bruno, P Cavallo-Perin, G Bargero, M Borra, V Calvi, N D'Errico, P Deambrogio and G Pagano
Institute of Internal Medicine, University of Torino, Italy.

OBJECTIVE: To determine the prevalence of micro- and macroalbuminuria in NIDDM and their relationship with some known and putative risk factors. RESEARCH DESIGN AND METHODS: Out of a population-based cohort of 1,967 NIDDM subjects, 1,574 were investigated (80%). Albumin excretion rate (AER) was evaluated on an overnight urine collection, and plasma and urine determinations were centralized. RESULTS: The prevalences of microalbuminuria (AER 20-200 micrograms/min), macroalbuminuria (AER > 200 micrograms/min), and hypertension were 32.1% (95% CI 29.8-34.4), 17.6% (15.7-19.5), and 67% (64.6-69.3), respectively. Apart from prevalence of hypertension, which after adjustment for age, BMI, and duration of diabetes was 2.3 times higher in women, rates were higher in men (odds ratio [OR] 1.31, 95% CI 1.04-1.66 for microalbuminuria and OR 1.63, 1.22-2.17 for macroalbuminuria). In comparison with normoalbuminuric subjects, both micro- and macroalbuminuric diabetic subjects had significantly longer duration of diabetes, higher levels of systolic blood pressure, fasting plasma glucose, HbA1c, triglycerides, and uric acid; in macroalbuminuric subjects only, levels of apolipoprotein B and HDL cholesterol were, respectively, higher and lower than in normo- and microalbuminuric subjects. In logistic regression, variables independently related to both micro- and macroalbuminuria were age, HbA1c, cigarette smoking habits, plasma uric acid, and diastolic blood pressure, after adjustment for plasma creatinine and diabetic treatment. In addition, duration of diabetes and HDL cholesterol levels were associated with macroalbuminuria. CONCLUSIONS: This population-based study showed high prevalence of micro- and macroalbuminuria in NIDDM subjects, who were characterized by a more adverse pattern of cardiovascular risk factors.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Unnikrishnan, M. Rema, R. Pradeepa, M. Deepa, C. S. Shanthirani, R. Deepa, and V. Mohan Prevalence and Risk Factors of Diabetic Nephropathy in an Urban South Indian Population: The Chennai Urban Rural Epidemiology Study (CURES 45) Diabetes Care, August 1, 2007; 30(8): 2019 - 2024. [Abstract] [Full Text] [PDF]

				R. Marin, P. Rodriguez, S. Tranche, J. Redon, F. Morales-Olivas, A. Galgo, M. A. Brito, J. Mediavilla, J. V. Lozano, C. Filozof, et al. Prevalence of Abnormal Urinary Albumin Excretion Rate in Hypertensive Patients with Impaired Fasting Glucose and Its Association with Cardiovascular Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S178 - S188. [Abstract] [Full Text] [PDF]

				R. Trevisan, A. R. Dodesini, and G. Lepore Lipids and Renal Disease J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S145 - S147. [Abstract] [Full Text] [PDF]

				J. Xu, E. T Lee, L. G Best, M. Begum, W. C Knowler, R. R Fabsitz, and B. V Howard Association of albuminuria with all-cause and cardiovascular disease mortality in diabetes: the Strong Heart Study The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 334 - 340. [Abstract] [PDF]

				G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, C. Runzo, S. Prina Cerai, G. Pagano, and P. Cavallo-Perin Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes: The Casale Monferrato Study Diabetes Care, November 1, 2004; 27(11): 2689 - 2694. [Abstract] [Full Text] [PDF]

				Polyunsaturated Fatty Acid Consumption May Play a Role in the Onset and Regression of Microalbuminuria in Well-Controlled Type 1 and Type 2 Diabetic People: A 7-year, prospective, population-based, observational multicenter study Diabetes Care, June 1, 2004; 27(6): 1454 - 1457. [Full Text] [PDF]

				M. K. Haroun, B. G. Jaar, S. C. Hoffman, G. W. Comstock, M. J. Klag, and J. Coresh Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2934 - 2941. [Abstract] [Full Text] [PDF]

				G. Bruno, A. Biggeri, F. Merletti, G. Bargero, S. Ferrero, G. Pagano, and P. C. Perin Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes: A 10-year prospective study Diabetes Care, August 1, 2003; 26(8): 2353 - 2358. [Abstract] [Full Text] [PDF]

				G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, G. Pagano, and P. C. Perin Progression to Overt Nephropathy in Type 2 Diabetes: The Casale Monferrato Study Diabetes Care, July 1, 2003; 26(7): 2150 - 2155. [Abstract] [Full Text] [PDF]

				S. R. Orth Smoking and the Kidney J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1663 - 1672. [Full Text] [PDF]

				B. P. Tabaei, A. S. Al-Kassab, L. L. Ilag, C. M. Zawacki, and W. H. Herman Does Microalbuminuria Predict Diabetic Nephropathy? Diabetes Care, September 1, 2001; 24(9): 1560 - 1566. [Abstract] [Full Text] [PDF]

				A Melville, R Richardson, D Lister-Sharp, and A McIntosh Complications of diabetes: renal disease and promotion of self-management Qual. Saf. Health Care, December 1, 2000; 9(4): 257 - 263. [Full Text]

				J.-M. Halimi and A. Mimran Renal effects of smoking: potential mechanisms and perspectives Nephrol. Dial. Transplant., July 1, 2000; 15(7): 938 - 940. [Full Text] [PDF]